Clinical Trials · NCT01579695
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- Theratechnologies
- Enrollment
- 391
- Start date
- Feb 2013
- Locations
- 31 sites, United States
- Primary endpoint
- Time to development of malignancies in HIV-infected subjects with abdominal lipohypertrophy exposed to EGRIFTA® vs. concurrent, comparable control group not exposed to EGRIFTA®